Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Professor Alison Simmons

Professor Alison Simmons FMedSci will start as Director of the Medical Research Council Human Immunology Unit (MRC HIU) from the 18 January 2021.

The MRC HIU aims to further our understanding of how the immune system functions to develop better treatment strategies against infectious diseases, cancer, allergy and autoimmune diseases. The Unit’s research spans basic to translational immunology focussed on the development of experimental medicine programmes.

Professor Simmons said: “I am delighted to be appointed as Director of the MRC Human Immunology Unit. The MRC HIU has a long and auspicious history of fundamental immune breakthroughs, pioneering the field of human immunology and extending discovery across a wide range of human immune and infectious diseases.

Recently, state of the art technological advances have led to description of immune pathogenesis in human tissues in unprecedented depth. This opens whole new possibilities to harness the immune system for health and in the HIU we hope to bridge that gap over the coming years. Our unique grouping of clinical, basic science and computational expertise will enable us to tackle these problems to drive innovation.”

The full story is available on the MRC Weatherall Institute of Molecular Medicine website

Similar stories

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.